Target-controlled Infusion of Propofol for Induction of Pediatric Anesthesia
NCT ID: NCT01411020
Last Updated: 2013-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2009-10-31
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Propofol for Pediatric Tracheal Intubation With Deep Anesthesia During Sevoflurane Induction
NCT01150838
Dose Titration of Propofol for Tracheal Intubation in Children With Sevoflurane Inhalation Induction
NCT01084031
Fentanyl and Propofol for Tracheal Intubation During Sevoflurane Induction Without Muscle Relaxants in Children
NCT02442128
Propofol Versus Sevoflurane for Induction of GA in Infants
NCT05105022
This Study Evaluated the Safety of Awake Extubation in Children at Risk for Respiratory Events Undergoing General Anesthesia.
NCT06936761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Grupo 1
Doses of induction: propofol 4 mcg/ml and fentanyl 3 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 2
Dose of induction: propofol 4.5 mcg/ml and fentanyl 3 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 3
Doses of propofol: propofol 5 mcg/ml and fentanyl 3 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 4
Doses of induction: propofol 5.5 mcg/ml and fentanyl 3 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 5
Doses of induction: propofol 6 mcg/ml and fentanyl 3 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 6
Doses of induction: propofol 4 mcg/ml and fentanyl 5 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 7
Doses of induction: propofol 4.5 mcg/ml and fentanyl 5 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 8
Doses of induction: propofol 5 mcg/ml and fentanyl 5 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 9
Doses of induction: propofol 5.5 mcg/ml and fentanyl 5 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Grupo 10
Doses of induction: propofol 6 mcg/ml and fentanyl 5 mcg/kg
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* children between 3 and 11 years
* healthy
* elective surgery under general anesthesia
* no premedication
Exclusion Criteria
* chronic or acute intake of any sedative drug
* any known adverse effect to the study drugs
3 Years
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pontificia Universidad Catolica de Chile
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricardo Fuentes Henriquez
Profesor Asistente, Departamento de Anestesiología
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clinico Universidad Catolica
Santiago, Santiago Metropolitan, Chile
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Munoz HR, Leon PJ, Fuentes RS, Echevarria GC, Cortinez LI. Prospective evaluation of the time to peak effect of propofol to target the effect site in children. Acta Anaesthesiol Scand. 2009 Aug;53(7):883-90. doi: 10.1111/j.1399-6576.2009.01995.x. Epub 2009 Jun 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hernan Muñoz
Identifier Type: -
Identifier Source: secondary_id
Ricardo Fuentes
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.